Caricamento...
Immune checkpoint inhibitor diabetes mellitus: a novel form of autoimmune diabetes
Autoimmune diabetes mellitus is a rare but significant side effect of treatment with immune checkpoint inhibitors. Immune checkpoint inhibitor‐induced diabetes mellitus (CPI‐DM) is characterized by acute onset of dramatic hyperglycemia with severe insulin deficiency and occurrence following exposure...
Salvato in:
| Pubblicato in: | Clin Exp Immunol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7160652/ https://ncbi.nlm.nih.gov/pubmed/32027018 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.13424 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|